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Abstract
Infants under 3 months of age with fever without source (FWS) generally undergo a full, invasive septic evaluation to exclude invasive
bacterial infection (IBI). Enterovirus (EV) infections are mostly banal and self-limiting and show a high prevalence rate at this age. We
aimed to investigate the prevalence of IBI in EV-infected and uninfected infants under 3 months of age with FWS. This was a prospective
observational cohort study of infants aged <90 days who were admitted because of FWS. As per protocol, blood and urine analysis and
culture were obtained in all cases, and RNA EV from blood and/or cerebrospinal ﬂuid samples was determined by real-time PCR. Three
hundred and eighty-one previously healthy infants with FWS were included. EV infection was diagnosed in 64 children (16.8%; 95% con-
ﬁdence interval, 13.2–20.9%) and showed an uneventful evolution in all cases. Laboratory markers of infection were consistently lower
in EV-infected patients; only one case of IBI (1.6%) was observed in an EV-infected patient as compared with 25.2% in EV-negative
infants (p <0.001). Intravenous antibiotic use and length of stay were no different in EV-infected and uninfected patients. In our study,
febrile infants (<90 days) diagnosed with EV infection showed a low risk of IBI when compared with uninfected patients. The systematic
investigation of EV infection in young infants with FWS may allow a more conservative approach to the management of these patients.
Further studies on this diagnostic approach are needed.
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Enteroviruses (EV) are single-strained RNA viruses that
belong to the Picornaviridae family, a large virus family com-
posed of more than 70 serotypes. These viruses remain a
major cause of febrile illness in children. Most of these infec-
tions are subclinical but they can also cause severe disease
[1,2]. The highest attack rates occur in children aged
<1 year. The reported prevalence of EV infection in patients
<12 months with a febrile event ranges from 15% to 50%
[1,3,4].
Fever without source (FWS) is one of the most frequent
reasons for consultation in paediatric emergencies, especially
in infants younger than 3 months. These patients have very
unspeciﬁc clinical signs, fever commonly being the only clini-
cal manifestation of the disease. About 8.5% of infants aged
under 90 days with fever will develop a potentially severe
invasive bacterial infection (IBI) [5,6]. Considering these data,
and according to published guidelines [7], these patients usu-
ally undergo aggressive diagnostic and therapeutic proce-
dures in the emergency room. EV infections may mimic
bacterial disease and often lead to unnecessary diagnostic
testing and antibiotic use, until a bacterial infection has been
ruled out. The ability to diagnose viral infections has
improved substantially in recent years, and because most feb-
rile infants are presumed to have viral infections, reaching a
speciﬁc diagnosis could contribute signiﬁcantly to their man-
agement. In fact, it is known that the diagnosis of a viral
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infection reduces the risk of suffering from IBI [6,8]. Simi-
larly, we recently reported a lower risk of positive blood or
urine cultures among infants with a positive rapid inﬂuenza
test [9], as previously described in febrile infants with respi-
ratory syncytial virus (RSV) infection [10,11]. In this study,
we aimed to determine the prevalence rate of EV infection
among febrile infants aged <90 days in our setting, by includ-
ing an EV real-time polymerase chain reaction (RT-PCR)
technique in the routine evaluation of these patients in the
Emergency Room. We also aimed to study how often EV
and IBI co-infections occur in these patients.
Materials and Methods
Patients and laboratory testing
During a 2-year period (August 2006–2008) prospective data
collection of patients <90 days of age admitted because of
FWS (a rectal temperature ‡38C) was carried out in a
monographic referral paediatric centre, located in Barcelona
(Spain), that attends to about 110 000 patients per year in
its Emergency Department. The study was reviewed and
approved by the local ethics committee and informed
consent was obtained from parents or legal guardians at
inclusion.
Our protocol for these patients (after clinical interview
and complete physical examination) includes a complete
blood count, blood bacterial culture, urinalysis and culture.
In all newborns (up to 28 days), and in all infants of any age
with malaise or laboratory alteration (white blood count
(WBC) ‡15 000/mm3 or £5000/mm3 or elevated reactive C
protein (CRP) ‡20 mg/L, or elevated procalcitonin (PCT)
‡0.5 ng/mL) [14,15], a lumbar puncture and cerebrospinal
ﬂuid (CSF) culture are also performed. All patients are
admitted and an intravenous empirical antibiotic is imple-
mented in most cases, except in patients who appear healthy
without laboratory alterations.
In addition, for this particular study, EV RNA was deter-
mined by means of real-time PCR from blood and/or CSF.
RNA extraction was performed using NucliSENS EasyMAG
(BioMe´rieux, Marcy l’Etoile, France). This method is based
on extraction using magnetic spheres. RNA extracts were
ampliﬁed with the MutaPLATE Enterovirus real time RT-
PCR (TaqMan) kit (Laboratories Immundiagnostik, Bensheim,
Germany) according to the manufacturer’s instructions. This
assay is a qualitative screening assay containing speciﬁc prim-
ers, TaqMan probes and additional material for the detection
of the 5¢-untranslated region (5¢-UTR) of the EV genome.
This procedure has been shown to be a fast (it can be car-
ried out in 5 h), standardizable, sensitive, speciﬁc and reliable
method for EV RNA detection [12,13]. It was performed
every 48–72 h depending on the number of samples to ana-
lyse. The cost of the technique was c. 140 US$ per sample.
Exclusion criteria were as follows: (i) patients with previ-
ous chronic disease(s), (ii) premature infants (gestational age
<37 weeks at birth), and (iii) patients for whom blood or
CSF samples were not available for EV PCR determination
(because they were transferred from other centers, or there
was insufﬁcient sampling or PCR inhibition).
Enterovirus infection was diagnosed upon the detection of
EV RNA in blood, CSF or both. Enteroviral meningitis was
deﬁned either by positive EV RNA in CSF (with or without
pleocytosis), or by positive blood EV RNA plus CSF
pleocytosis (with or without EV RNA positivity in CSF).
The results of all bacterial cultures were obtained from
computerized microbiology records. Invasive bacterial infec-
tion was deﬁned as follows. (i) Bacteraemia: the presence of
a bacterial pathogen in the blood culture; Staphylococcus
epidermidis and Streptococcus viridans were considered as
contaminating microorganisms. (ii) Urinary tract infection:
>10 000 colony forming units/ml in a sterile urine sample.
(iii) Bacterial meningitis: deﬁned as the growth of a micro-
organism in CSF. (iv) Bacterial pneumonia: deﬁned as a sug-
gestive image on chest X-ray, whether blood or pleural
positive cultures were associated or not. (v) Bacterial
enteritis: diagnosed with the growth of a microorganism in
stool culture. (vi) Osteoarticular infection: revealed by sug-
gestive image tests (gammagraphy or magnetic resonance)
and/or by a positive culture of the sample obtained from
the affected zone. (vii) Infection of soft tissues (cellulites or
similar): diagnosed by clinical examination, with or without
positive blood or pus cultures.
Data analysis
Data were analysed with the statistical package SPSS v15.0
for Windows (SPSS Inc., Chicago, IL, USA). Continuous vari-
ables were described with mean and standard deviation, or
median and interquartile range. Discrete variables were
described with frequencies and percentage, with a 95% conﬁ-
dence interval. Comparison of means was carried out using
the Student t-test for independent samples, while frequencies
were analysed by contingency tables and v2.
Results
During the 24-month study period, a total of 381 (179
females, 47%; mean age: 35 days, standard deviation (SD):
21 days) patients with FWS under 3 months of age, fulﬁlling
inclusion criteria, were admitted to our centre and included
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in the study (Fig. 1). At admission, the mean (SD) of the
fever peak was 38.4C (0.2), with a median of 6 h (p25–75:
3–12 h) evolution. The most common complaints were rhin-
orrhea (27%), irritability (23%), refusal of food (21%) and
gastrointestinal symptoms (19%).
Discharge diagnoses of all patients are summarized in
Table 1.
Blood and urine cultures were performed in all patients.
Lumbar puncture was performed in 255 (74.8%) patients.
Thirty (7.8%) positive blood cultures were observed; almost
half of them (14 out of 30) were considered as contami-
nated. The remaining 16 blood cultures tested positive for:
Streptococcus agalactiae (n = 6), Escherichia coli (n = 9) and
Proteus mirabilis (n = 1). All gram-negative bacteraemias were
secondary to urinary tract infections.
Urine cultures were positive in 65 cases: E. coli in 57
cases, Klebsiella pneumoniae in three cases, and K. oxytoca,
Enterobacter cloacae, P. mirabilis, Citrobacter koseri and S. aga-
lactiae in one case each.
Meningitis was diagnosed in 39 cases; all CSF bacterial cul-
tures tested negative. Enteroviral meningitis was diagnosed in
32 out of 39 infants with CSF pleocytosis; in seven cases, no
germ was identiﬁed.
Blood EV PCR was performed in all but 83 patients,
either because of insufﬁcient sampling or PCR inhibition;
cerebrospinal ﬂuid EV PCR was performed in 237 infants.
Enterovirus infection was diagnosed in 64 patients (56.3%
male; prevalence rate, 16.8%; 95% conﬁdence interval (CI),
13.2–20.9%; Fig. 2), 44 (68.8%) of them during March to
August (Fig. 2). Enterovirus was considered as the aetiology
of FWS in 62 patients: FWS (n = 25), aseptic meningitis
(n = 32), acute gastroenteritis (n = 3) and upper respiratory
tract infection (n = 2). Co-infection occurred in two
patients: a 27-day-old neonate with inﬂuenza A and EV co-
infection, who was ﬁnally diagnosed with ﬂu; and a 37-day-
old infant with a urinary tract infection caused by S. agalac-
tiae and an EV co-infection. Three infants, none of them
EV-infected, required admission to the intensive care unit: a
newborn aged 9 days with hypoxaemia secondary to RSV
bronchiolitis that developed after admission; a 47-day-old
infant because of urinary sepsis; and an infant aged
2 months, because of aseptic meningitis and secondary ap-
noeas. No patient died.
Comparison of patients with positive EV PCR and negative
EV PCR
Age or clinical symptoms at presentation did not differ
between EV-positive and EV-negative patients, except for
exanthema (more common among EV-positive patients) and
rhinorrhea (less common among EV-positive infants). Labora-
tory markers of infection were consistently lower in patients
infected with EV (Table 2). It is important to note that only
two infants with EV infection (ﬁnally diagnosed with sterile
enteritis and FWS, respectively) showed PCT values higher
than 2 ng/mL. The number of patients receiving empirical
antibiotics at admission, the length of antibiotic therapy and
duration of hospital stay did not differ between EV-positive
and EV-negative patients.
Prevalence of IBI
As previously mentioned, only one case of IBI was diagnosed,
in one of the 64 patients diagnosed with EV infection (a 37-
day-old infant with a urinary tract infection caused by S. aga-
lactiae). This represents a 1.6% (95% CI: 0.04–8.4%) preva-
lence rate for IBI among EV-positive patients, signiﬁcantly
lower than the prevalence of IBI in EV-negative patients (80
out of 317 cases; 25.2%; 95% CI, 20.4–30.0%; p <0.001).
381 patients included
144 patients EV determination only in blood
83 patients EV determination only in CSF
154 patients EV determination in both samples
317 patients EV negative 64 patients EV positive
14 only CSF
34 only in blood
16 both samples
FIG. 1. Algorithm summarizing the patients included in the study
according to ﬁnal results regarding EV infection. EV, enterovirus;
CSF, cerebrospinal ﬂuid.
TABLE 1. Discharge diagnosis
Diagnosis n = 381 EV) (n = 317) EV+ (n = 64)
Invasive bacterial infection
Urinary tract infection 65 64 1
Sepsisa 7 7 0
Pneumonia 4 4 0
Acute gastroenteritisb 4 4 0
Cutaneous cellulitis 1 1 0
Non-invasive bacterial infections: viral or presumable viral infections
Febrile syndrome without source 174 149 25
Aseptic meningitis 39 7 32
Acute gastroenteritis 27 24 3
Upper respiratory tract infection 24 22 2
Acute otitis media 15 15 0
Fluc 12 11 1
Bronchiolitisd 10 10 0
aStreptococcus agalactiae (n = 6) and Escherichia coli, one patient.
bRotavirus (n = 4), Campylobacter jejunii and Salmonella enteritidis (two cases
each).
cInﬂuenza type A (n = 10) and B (n = 2).
dRespiratory syncitial virus detected in six cases.
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Discussion
The majority of febrile children who present at primary care
and emergency departments are younger than 3 years of age.
Twenty per cent of them have FWS, occult bacteraemia
occurring in 3% of cases. The percentage of bacterial infec-
tions increases in infants aged <3 months, by up to 10%
[5,7,16]. The evaluation and management of these infants are
controversial because of the non-speciﬁcity of clinical symp-
toms and signs [17]. In these infants, the most prevalent
causes of fever are viral infections, which are associated with
a reduction in the risk of IBI [6]. Among them, EV remains a
major cause of febrile illness [1,17]. However, recent guide-
lines on the management of infants with FWS do not include
a systematic detection of viral infections in these patients
[18].
To our knowledge, this is the ﬁrst prospective study to
investigate the role of EV infection in febrile infants under
90 days of age in our geographical area. Ahmed et al. [19]
determined that PCR assay of CSF is useful for the rapid and
reliable diagnosis of EV meningitis in these young infants,
while Ritticher et al. [17] identiﬁed EV as the cause of FWS
in 20% of young infants by means of EV PCR in blood and
CSF samples. Both studies were performed in the United
States. In our experience, EV infection was identiﬁed as the
cause of fever in 64 of the 381 studied subjects; this preva-
lence rate (16.8%) is similar to that described in the litera-
ture [3,6,17,20,21]. Of note, most EV infections were
observed from March to August, earlier in time than the
classical EV season, which has usually been described as in
the summer and fall months [17,22]. Patients diagnosed with
EV were mostly newborns (56.3%), as Ritticher [17]
described in her series. Twenty per cent of EV-infected
patients were younger than 14 days and more than 37%
were younger than 28 days. Rotbart [23] also described a
high rate of EV infection (47%) in patients under 30 days of
age. In our series, only three patients were 7 days old or
less at the time of diagnosis of EV infection; most severe
cases of EV-related illnesses have been described in these
very young infants [2,24–26]. The rate of EV infection among
neonates might have been overestimated in our study by the
fact that lumbar puncture was systematically performed in all
patients under 28 days, but not in those patients aged over
1 month.
In our cohort, 84.2% of cases of meningitis were caused
by EV and, among all EV-positive patients, half of them were
diagnosed with meningitis, as previously reported [18,19]. It
is important to note that 41.6% of EV meningitis did not
show pleocytosis, a ﬁnding that has been associated with
young ages (<90 days) by other authors [17,22].
The IBI prevalence in EV-infected infants has been
described as being close to 7%, mostly consisting of urinary
TABLE 2. Clinical data and test results and management









Fever (mean C) 38.5 38.4 NS
Evolution (mean hours) 10.94 10.93 NS
Symptoms (%)
Irritability 25.9 23.2 NS
Food refusal 15.9 23.9 NS
Rhinorrhoea 8.6 30.8 <0.001
Gastrointestinal symptoms 19 20 NS
Exanthema 6.9 1.7 <0.05
Laboratory tests
White blood cell count/mm3 (mean) 10 296 13 038 <0.001
Total neutrophil count/mm3 (mean) 4209 6300 <0.001
Band neutrophil count/mm3 (mean) 242 487 <0.005
CRP (mg/l) (mean) 12.8 25.7 <0.001
PCT (ng/dL) (mean) 0.58 1.80 <0.01
White CSF cells/mm3 (mean) 246.25 60.72 <0.05
Management and evolution
Antibiotic treatment 75.4% 73.4% NS
Median length of antibiotic
treatment (days)
2.4 2.9 NS
Median length of stay (days) 3.7 4.1 NS
n
FIG. 2. Monthly distribution of EV cases.
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tract infections [6,17,18,27]. We only detected one patient
affected with a urinary tract infection (that had already
been diagnosed and treated in the emergency room) and
EV co-infection. Despite this, nearly 75% of EV-infected
infants received intravenous antibiotic treatment for at least
72 h, pending the results of bacterial cultures, and length of
stay was not different between EV-infected and uninfected
children. The fact that EV PCR was performed in our labo-
ratory only every 48–72 h, should not be forgotten. Simi-
larly, Rotbart [23] reported that 94% of their cohort of
EV-infected infants received at least one dose of parenteral
antibiotic and more than 80% of them were admitted to
hospital.
Other studies in EV-infected infants have shown a reduc-
tion in the number of days of hospitalization because of early
obtaining of PCR results in the ﬁrst 24 h after admission.
Nigrovic and Chiang [28] demonstrated that when the preva-
lence of EV meningitis is higher than 6%, systematic EV
determination by PCR is cost-effective as it prevents unnec-
essary antibiotic therapy and hospital admissions. King et al.
[29], in a retrospective review of 478 patients aged <90 days
in whom CSF EV PCR was determined, also concluded that
conﬁrmed EV meningitis would potentially reduce the length
of stay and the duration of antibiotic treatment, as has been
suggested by other authors as well [17,20,30].
Our study has several limitations, including its observa-
tional design, the fact that both CSF and blood EV PCR
determination were not performed in all patients, and a
potential under-diagnosis bias in infants with afebrile EV
infection. Finally, other viral co-infections were not system-
atically investigated and probably were missed in some
cases.
In summary, our results suggest that febrile infants
(<90 days) diagnosed with EV infection show a low risk of
IBI when compared with uninfected patients. The systematic
investigation of EV infection in young infants with FWS in the
emergency department during March to August, when the
prevalence of EV infection is higher in our geographical area,
may allow a more conservative approach to the management
of these patients, and ultimately, decrease the need for anti-
biotic use and the length of hospitalization. Until randomized
clinical trials on this issue are available, current recommenda-
tions on the management of young infants with FWS should
be strictly followed.
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